Arrayed CRISPR screen with image-based assay reliably uncovers host genes required for coxsackievirus infection by Kim, Heon Seok et al.
Arrayed CRISPR screen with image-based assay
reliably uncovers host genes required
for coxsackievirus infection
Heon Seok Kim,1,2,5 Kyungjin Lee,3,5 Seong-Jun Kim,3 Sungchan Cho,4 Hye Jin Shin,3
Chonsaeng Kim,3 and Jin-Soo Kim1,2
1Center for Genome Engineering, Institute for Basic Science, Seoul 151-747, South Korea; 2Department of Chemistry, Seoul National
University, Seoul 151-747, South Korea; 3Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of
Chemical Technology, Daejeon 34114, South Korea; 4Anticancer Agent Research Center, Korea Research Institute of Bioscience &
Biotechnology, Cheongju 28116, South Korea
Pooled CRISPR screens based on lentiviral systems have been widely applied to identify the effect of gene knockout on cel-
lular phenotype. Although many screens were successful, they also have the limitation that genes conferring mild pheno-
types or those essential for growth can be overlooked, as every genetic perturbation is incorporated in the same population.
Arrayed screens, on the other hand, incorporate a single genetic perturbation in each well and could overcome these
limitations. However, arrayed screens based on siRNA-mediated knockdownwere recently criticized for low reproducibility
caused by incomplete inhibition of gene expression. To overcome these limitations, we developed a novel arrayed CRISPR
screen based on a plasmid library expressing a single guide RNA (sgRNA) and disrupted 1514 genes, encoding kinases,
proteins related to endocytosis, and Golgi-localized proteins, individually using 4542 sgRNAs (three sgRNAs per gene).
This screen revealed host factors required for infection by coxsackievirus B3 (CVB3) from Picornaviridae, which includes hu-
man pathogens causing diverse diseases. Many host factors that had been overlooked in a conventional pooled screen were
identified for CVB3 infection, including entry-related factors, translational initiation factors, and several replication factors
with different functions, demonstrating the advantage of the arrayed screen. This screen was quite reliable and repro-
ducible, as most genes identified in the primary screen were confirmed in secondary screens. Moreover, ACBD3, whose
phenotype was not affected by siRNA-mediated knockdown, was reliably identified. We propose that arrayed CRISPR
screens based on sgRNA plasmid libraries are powerful tools for arrayed genetic screening and applicable to larger-scale
screens.
[Supplemental material is available for this article.]
Functional genetic screens are generally performed using two dif-
ferent methods: pooled or arrayed. Genetic screens using the clus-
tered regularly interspaced repeat (CRISPR)-CRISPR-associated
(Cas) system have been widely applied to various systems to reveal
relationships between phenotypes and genes (Koike-Yusa et al.
2014; Shalemet al. 2014;Wang et al. 2014). However,most screens
are conducted in a pooled format, which uses lentiviruses to
deliver a genome-wide library of single guide RNAs (sgRNAs).
Pooled screens have some advantages, including easy preparation
and reduced labor. Although highly sensitive pooled assays could
identify the phenotypes that are mild or that have growth disad-
vantages (Gilbert et al. 2014), pooled assays, in general, are not
compatible with these phenotypes. On the other hand, arrayed
screens that are conducted by singular reagents arranged in a mul-
tiwell format could overcome these limitations, as eachwell has in-
dividual genetic perturbations. However, small interference RNA
(siRNA) library screens, which are the most representative arrayed
screenmethod, are recently being criticized for low reproducibility
induced by high off-target effects and incomplete gene knock-
down (Buehler et al. 2012; Kaelin 2012). In contrast, genome edit-
ing based on CRISPR-Cas9 results in complete knockout of the
target gene. Furthermore, off-target effects can be greatly reduced
by selecting unique target sites and modifying guide RNAs (Bae
et al. 2014b; Cho et al. 2014; Fu et al. 2014). These comparative ad-
vantages of the CRISPR system could help overcome the limita-
tions of siRNA library screening. Arrayed CRISPR screens could
be a very useful platform to fill the caveats of pooled CRISPR
screens and siRNA library screens.
Some groups have previously attempted to develop arrayed
CRISPR screens (Hultquist et al. 2016; McCleland et al. 2016;
Tan and Martin 2016; Datlinger et al. 2017; Strezoska et al.
2017). These studies were based on guide RNA libraries consisting
of individual lentiviral sgRNAs for single genes or synthesized
CRISPR RNA (crRNA) in a manner similar to siRNA screens.
Although these prior studies have their strengths, they also have
some weaknesses. Arrayed lentiviral particles are cumbersome to
prepare because each lentiviral vector should be delivered to pack-
aging cell lines individually. Moreover, challenges such as cross-
contamination and variable lentiviral titers in the multiwell plate
make it difficult to apply lentiviral particles to arrayed screens on a
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large scale. Furthermore, because of the low expression of sgRNAs
and the additional time to select out the untransduced cells with
selection marker, it will take more time for screening. This could
also be another drawback of the lentiviral method in arrayed
screens because a long culture period is not feasible in multiwell
plates. Although synthetic crRNA is easier to prepare compared
to lentivirus particles, RNA synthesis is cost-inefficient.
In this study, we present a new CRISPR screen method using
an arrayed library of sgRNAs to identify essential host genes for
coxsackievirus infection. Delivery of Cas9 and sgRNA expression
plasmids is the most frequently applied method because of sim-
plicity and high expression levels of both components, which
result in high efficiency of genome editing in eukaryotic cells
over 2–3 d. With respect to rapid and highly efficient genome ed-
iting, this method would reduce the signal-to-noise levels in high-
throughput assays, thus improving the reliability and sensitivity of
genetic screening.
Enteroviruses from the Picornaviridae family are human path-
ogens that cause a wide range of illnesses, including aseptic men-
ingitis, encephalitis, and myocarditis (Fields et al. 2007). These
viruses depend on host proteins for their life cycle. Determining
the role of host factors in viral infection would help with under-
standing the basic aspects of virus-host interaction and exploring
novel therapeutic targets. Host factors that are indispensable for
viruses and affect host cells minimally would be ideal targets. We
chose coxsackievirus B3 (CVB3), which is a member of human en-
teroviruses. Some groups have reported that CVB3 exploits kinas-
es, proteins in endocytic pathways, and Golgi-localized proteins
for its infection (Coyne and Bergelson 2006; Lanke et al. 2009;
Patel et al. 2009). To further investigate the host factors required
for CVB3 infection, we selected up to 1514 encoding kinases, pro-
teins related to endocytosis, and Golgi-localized proteins. We con-
structed a plasmid library expressing sgRNA targeting these 1514
genes (three sgRNAs per gene, 4542 sgRNAs) and performed a
high-throughput screen to identify the genes required for CVB3
infection.
Results
Pooled lentiviral CRISPR screen to identify host factors for
CVB3 infection
To compare the commonly used pooled screen with the arrayed
screen, a lentivirus-based pooled sgRNA screen was conducted to
uncover the host genes essential for CVB3. The GeCKOv2
CRISPR knockout pooled library, which is the most widely used,
was transduced into HeLa cells at 0.3 multiplicity of infection
(MOI), and sgRNA-expressing cells were selected with puromycin.
Two weeks later, these cells were subjected to CVB3 infection. We
performed targeted deep sequencing for 100× coverage using
genomic DNA isolated from hundreds of surviving cells and
compared the abundance of sgRNAs from the initial popula-
tion and the cells surviving after the CVB3 infection, using
Model-based Analysis of Genome-wide CRISPR-Cas9 Knockout
(MAGeCK) software (Supplemental Fig. S1A; Li et al. 2014). Only
one gene, CXADR (Coxsackievirus and adenovirus receptor),
which is well known as the receptor of CVB3, was shown as a
strong candidate (Supplemental Fig. S1B). Though the lentivirus-
based CRISPR screen was easy to perform, we wondered if we
had missed other important host factors using this pooled screen.
Therefore, we tried to screen each gene one by one in an arrayed
format.
Arrayed CRISPR screens
To identify host factors for CVB3 infection in an arrayed format,
we developed an image-based assay using sgRNA plasmids. As
a proof-of-principle, we chose two genes: CXADR and PI4KB.
CXADR is well-known as the receptor of CVB3, which was also
identified from the pooled screen, and PI4KB is an essential factor
for CVB3 replication (Bergelson et al. 1997; Hsu et al. 2010). We
first transfected three sgRNA plasmids targeting CXADR and
PI4KB into HeLa cells, along with the Cas9 expression plasmid to
induce mutations in each gene. Mutations were induced very effi-
ciently, and 71% and 80% of alleles were disrupted, respectively.
As CRISPR knockout generally requires more time to show pheno-
types compared to siRNA, experimental conditions like cell
number and incubation time after transfection were optimized.
To maximize Cas9-mediated mutation and minimize the effect
of residual mRNA and proteins, we incubated the transfected cells
for 5 d and then infected them with CVB3. The cells were then
fixed and stained with the anti-3C rabbit polyclonal antibody
and AF-488-conjugated anti-rabbit goat antibody. Images were ac-
quired using the high-content imaging system, Operetta. The
CVB3 infection level was significantly reduced when the host fac-
tor-targeting sgRNAs were transfected, compared to that using the
nontargeting sgRNA (Fig. 1A,B). This result implies that the ar-
rayed sgRNA library, based on plasmid expression, could be useful
for screening. Additionally, this image-based assay, which stains
viral protein directly, could reduce the artifacts driven by other as-
says, including reporter cells detecting viral infection (Park et al.
2017). To identify novel host factors for CVB3 infection, we chose
three groups of genes encoding 469 kinases, 310 proteins related
to endocytosis, and 735 Golgi-localized proteins, which are poten-
tial host factors for viral infection. Using a library of individually
synthesized oligonucleotides, which encode sgRNAs targeting
the human genome that we have described previously (Kim et al.
2017), we prepared an arrayed sgRNA plasmid library in the 96-
well format consisting of three target sites per gene for 1514 genes.
We carefully designed those target sites to be unique in the human
genome and to have a high microhomology score to avoid in-
frame mutations as much as possible (Bae et al. 2014a, b). To fur-
ther reduce off-target effects, we added two extra guanine nucleo-
tides to produce ggX20 sgRNAs (Cho et al. 2014; Kim et al. 2015)
and carefully designed three sgRNA target sites that differ from
any other site in the human genome by at least 3 nucleotides
(nt), which is considered a more important criterion than the
microhomology score. To examine the activity of this library, we
investigated the gene disruption rate after transfecting sgRNAs tar-
geting 35 genes. Most of the genes were knocked out efficiently,
implying that this library is useful and reliable. The average muta-
tion rate for 35 genes was quite high at 72.8% (Fig. 1C). The aver-
age out-of-frame ratio was 76.3%.
We performed an arrayed CRISPR screen based on the plas-
mid sgRNA library for 1514 genes in duplicate (Fig. 2A). We calcu-
lated the Z score for CVB3 infection rate reduction for each plate
and identified the candidate genes with Z <−1.8 in the duplicate
screens (Supplemental Fig. S2A; yellow box indicates the region
for candidate genes). From the primary screens, we chose 10 genes
as candidates (Supplemental Fig. S2B). To confirm these results,
the same sgRNAs used in the screen were transfected again into
HeLa cells along with Cas9 and then the infection rate was mea-
sured (Fig. 2B). Most of the genes, except two from the primary
screens, were confirmed by reduced infectivity. To further verify
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gene and found that CVB3 infection was significantly inhibited
(Fig. 2C). Of the 10 genes identified in the primary screen, eight
were confirmed in the secondary screens, which are derived by ex-
perimental and statistical errors in arrayed screen. This result
shows that the arrayed CRISPR screen is quite reliable and
reproducible.
To directly compare arrayed and
pooled approaches, we next investigated
whether these eight genes could be
identified using a pooled library of 4542
sgRNAs targeted to the same 1514 genes.
This focused, pooled library was trans-
duced into HeLa cells at 0.3 MOI. Two
weeks later, these cells were subjected
to CVB3 infection. Targeted deep se-
quencing revealed that only one gene,
CXADR, was identified as a strong can-
didate (Supplemental Fig. S3). Note that
we identified the same gene using the
GeCKOv2 library (Supplemental Fig. S1).
DNM2, FASN, OSBP, and SACM1L are
known to be important for enterovirus
infection
It has been previously reported that some
candidates are required for coxsackievi-
rus infection. Dynamin 2 protein encod-
ed by DNM2 is required for CVB3 entry
(Patel et al. 2009). Fatty acid synthase
encoded by FASN is required for CVB3
replication (Wilsky et al. 2012). OSBP
and SACM1L are required for sterol/PI(4)P exchange at the ER-
Golgi interface, and rhinovirus and enterovirus, which belong to
Picornaviridae like CVB3, use these processes for viral replication
(Mesmin et al. 2013; Roulin et al. 2014; Strating et al. 2015). Our
screening results are in agreement with these previous reports
and give us confidence in our approach. The proteins encoded
CA
B
Figure 1. Plasmid-based sgRNA constructs as a tool for a genetic perturbation screen in human cells.
(A,B) HeLa cells were transfected with sgRNA-expressing plasmids (Control, CXADR, and PI4KB) and in-
fected with CVB3 at anMOI of 5. At 8 h post-infection, cells were fixed and stainedwith anti-3C antibody
(green) and DAPI (blue). (A) Quantification of infection. Mean ± SEM for quadruplicate experiments.
(∗∗) P < 0.01. (B) Representative images of infection are shown. (C) Mutation frequencies determined af-




Figure 2. Candidate identification. (A) Schematic presentation of the arrayed CRISPR screen. (B) Quantification of CVB3 infection in HeLa cells transfected
with sgRNA-expressing plasmids targeting 10 genes from primary screens. Mean ± SEM for quadruplicate experiments. (∗∗) P < 0.01, (n.s.) nonsignificant.
(C) Similar quantification of virus infection in B using newly designed sgRNA. (D) The percentage of CVB3-infected cells (normalized to DMSO control)
treated with three known inhibitors of the candidates. Mean ± SD for triplicate experiments. (E) HeLa cells were transfected with ACBD3 and CSDE1 target-
ing sgRNAs and infected with CVB3. Surviving cells were stained and are shown. Surviving colonies were expanded and the target regionwas sequenced to
confirm themutations. Red characters indicate the PAM and blue characters indicate insertions. hg19 is the wild-type sequence of each gene. As our target
sites have the same sequence in both references (i.e., hg19 and GRCh38), using GRCh38 would not significantly affect our conclusions.
Arrayed CRISPR screen with image-based assay
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by DNM2, FASN, and OSBP have known chemical inhibitors:
Dynasore, C75, and Itraconazole (ITZ), respectively. As expected,
CVB3 infection was dramatically reduced by these chemicals
(Fig. 2D). In contrast, cell viability was not affected at the same
concentrations (Supplemental Fig. S4).
sgRNAs against CSDE1 and ACBD3 make cells resistant to CVB3
Unlike siRNAs, sgRNAs coupledwith Cas9 induce permanent gene
knockout at the target sites. We examined whether knocking out
the candidate genes could make cells completely resistant to
CVB3 infection. Genes thatmake cells resistant to virus after being
knocked out could be important antiviral drug targets because
these host factors are absolutely required for virus infection but
are not essential for cell viability and proliferation. sgRNAs target-
ing the cold shock domain containing E1 (CSDE1) and the acyl-
CoA binding domain containing 3 (ACBD3) were found to induce
CVB3-resistance without preventing cell proliferation (Fig. 2E). As
expected, these resistant colonies hadmutations at the CSDE1 and
ACBD3 target sites (Fig. 2E). However, sgRNAs targeting other
genes like DNM2, FASN, and OSBP, although proved to be impor-
tant host factors by using chemical inhibitors (Fig. 2D), could
not generate CVB3-resistant clones (Supplemental Fig. S5). We
also tried to isolate KO clones for these genes, but we could not
obtain them. This suggests that they are essential factors for cell
proliferation, as previously reported (Blomen et al. 2015).
Accordingly, we choseCSDE1 and ACBD3 for further study among
the candidates.
CSDE1 is required for CVB3 infection,
especially in IRES-dependent translation
We isolated a CSDE1 KO cell line for
functional study and found that these
cells were resistant to CVB3 infection at
various MOIs (Fig. 3A). Moreover, they
did not permit viral replication, as shown
by the CVB3 replicon assay expressing
the luciferase reporter in place of the P1
structural region and an immunostain-
ing assay (Fig. 3B; Supplemental Fig.
S6). Western blot analysis also showed
the absence of CSDE1 protein (Fig. 3C).
CVB3 infection and replication was
rescued when we transfected the eGFP-
CSDE1 plasmid into CSDE1 KO cells
(Fig. 3B,C). These results suggest that
CSDE1 is a key host factor for CVB3 in-
fection. CSDE1 was previously known
to be required for internal initiation
of translation of the human rhinovirus
internal ribosome entry site (IRES)
(Hunt et al. 1999; Anderson et al.
2007). As human rhinovirus and CVB3
both belong to the Enterovirus genus
and share similar genomic structure, we
hypothesized that CSDE1 might be
related to translation initiation directed
by the CVB3 IRES as well. A dual lucifer-
ase reporter system, which encodes fire-
fly luciferase under the IRES sequence
of CVB3 and constitutively expresses
Renilla luciferase upstream of them, was
used to confirm this hypothesis (Paek et al. 2008; Kang et al.
2015). CVB3 IRES sequences could not initiate translation in
CSDE1-depleted cells as efficiently as in wild-type cells (Fig. 3D).
To further investigate whether CSDE1 is required for IRES-depen-
dent translation in other viruses, a similar dual luciferase reporter
system for four different viruses, Poliovirus 1 (PV1), Enterovirus
71 (EV71), Hepatitis C virus (HCV), and Encephalomyocarditis
virus (EMCV), was used (Paek et al. 2008; Kang et al. 2015).
Concerning the four IRES sequence origins, PV1 and EV71 belong
to the same Enterovirus genus. IRES sequences from these could not
initiate translation in CSDE1-depleted cells (Fig. 3D). In contrast,
the other two IRES sequences (HCV and EMCV) could initiate
high-level translation in both cells, indicating that CSDE1 is an
important factor for IRES-dependent translation, especially in
the human Enterovirus genus. These results suggest that CSDE1
could be a valuable target for development of broad-spectrum an-
tivirals against diverse enteroviruses that cause numerous diseases
in humans.
ACBD3 is required for CVB3 infection but influences cell
growth minimally
Another candidate, ACBD3, was also interesting because some
groups have reported that ACBD3 is dispensable for PV1 and
CVB3 replication through siRNA knockdown (Teoule et al. 2013;
Dorobantu et al. 2014). In contrast, we could obtain CVB3-resis-
tant cells after sgRNA transfection. To further investigate the role
BA
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Figure 3. CSDE1 is required for CVB3 infection. (A) Viability of wild-type (HeLa) and CSDE1 knockout
(KO) cells after CVB3 infection. (B) Viral replication test of wild-type (HeLa) and CSDE1 KO cells using the
CVB3 replicon. Transfection with cDNA encoding the eGFP-CSDE1 protein into CSDE1 KO cells rescued
CVB3 replication. (C) Transfection with cDNA encoding the eGFP-CSDE1 protein into CSDE1 KO cells res-
cued CVB3 infection. After 8 h of CVB3 infection in wild-type (HeLa) and CSDE1 KO cells transfected with
the plasmid encoding the eGFP-CSDE1 protein, cells were harvested and lysed for western blot analysis
using anti-CSDE1 antibody, anti-VP1 antibody, and anti-beta actin antibody. (D) CVB3 IRES-dependent
translation assay of wild-type (HeLa) and CSDE1 KO cells. Dual luciferase reporter plasmids containing the
IRES sequence from five different viruses were transfected into cells and the activity of firefly luciferase and
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of ACBD3 in CVB3 infection, ACBD3 KO clones were isolated.
ACBD3 knockout clones were resistant to CVB3 and blocked
CVB3 replication completely, as shown by the CVB3 replicon as-
say (Fig. 4A,B). Western blotting and an immunostaining assay
also showed that viral protein expressionwas significantly inhibit-
ed in these cells (Fig. 4C; Supplemental Fig. S7). Ectopic expression
of FLAG-tagged ACBD3 protein rescued CVB infection, replica-
tion, and viral protein expression (Fig. 4B,C; Supplemental Fig.
S8). Sasaki et al. (2012) reported that the Aichi virus of the
Picornaviridae family recruits ACBD3 and PI4KB to RNA replication
sites and the viral protein 3A interacts with ACBD3 for recruit-
ment. Lei et al. (2017) also reported that ACBD3 facilitates entero-
virus 71 replication by interacting with the 3A protein. These
reports, combined with our results, suggest that ACBD3 is broadly
required for human enterovirus replication. To confirm the inter-
action between ACBD3 and the human enterovirus 3A protein, we
conducted a simple luciferase assay with
a mammalian two-hybrid system. Both
3A proteins from CVB3 and PV1 fused
with the DNA-binding domain increased
luciferase expression only in combina-
tion with the ACBD3 protein fused with
the transcription activation domain
(Fig. 4D). These results indicate that the
CVB3 3A protein interacts with ACBD3
and CVB3 uses ACBD3 as an essential
host factor similar to that in Aichi virus
or enterovirus 71. As ACBD3 is broadly
required for enteroviruses infection, this
protein might be valuable target for the
development of broad spectrum antiviral
inhibitors. It is necessary that this host
factor be essential for the virus but have
a minimal effect on cell proliferation.
To determine whether knocking out
this protein could influence cell growth,
we compared the growth of ACBD3 KO
clones with control HeLa cells (Fig. 4E).
ACBD3 KO clones showed growth pat-
terns similar to those of HeLa cells.
These results suggest that ACBD3 is re-
quired for CVB3 infection but minimally
influences cellular proliferation.
Arrayed CRISPR screen reliably
identifies host factors difficult to find
using siRNAs
Since siRNA is the most widely used tool
in arrayed screens, we tried to compare
it with CRISPR. To do so, we performed
CVB3 infection in cells transfected with
siRNAs or sgRNAs targeting CSDE1
and ACBD3. Both the knockdown by
siRNAs and knockout by sgRNAs of
CSDE1 showed reduction in CVB3 infec-
tion (Fig. 5A). However, knockdown of
ACBD3 could not restrict CVB3 infection
in contrast to ACBD3 knockout (Fig. 5A).
Moreover, ACBD3 knockdown failed
to make HeLa cells resistant to infection
and block viral replication (Supplemen-
tal Fig. S9), even though knockdown efficiency of siRNA was
high for both genes (Fig. 5B,C). This indicates that even a trace
amount of ACBD3 protein could be sufficient for the virus, ex-
plaining why this gene was disputed in the previous studies using
siRNAs. Another candidate, RACK1, also showed a pattern similar
to ACBD3. Both siRNA and sgRNA against RACK1 showed good re-
duction of protein levels (Supplemental Fig. S10B). CVB3 infection
was significantly inhibited by sgRNA but was modestly inhibited
by siRNA (Supplemental Fig. S10A). This suggests that screening
with sgRNAs could reduce the false-negatives induced by the in-
complete knockdown events with siRNAs.
Discussion
In this study, we report a novel, high-throughput arrayed CRISPR




Figure 4. ACBD3 is required for CVB3 replication. (A) Viability of wild-type (HeLa) and ACBD3 knockout
(KO) cells after CVB3 infection. (B) Viral replication assay of wild-type (HeLa) and ACBD3 KO cells using the
CVB3 replicon. Transfection with cDNA encoding FLAG-tagged ACBD3 protein into ACBD3 KO cells res-
cued CVB3 replication, as shown by a viral replication assay using the CVB3 replicon. (C) Wild-type HeLa
cells and ACBD3 KO cells transfected with control and plasmid encoding FLAG-tagged ACBD3 protein
were infected with CVB3 at an MOI of 5. At 8 h post-infection, cells were fixed and stained with anti-
3C antibody (green) and DAPI (blue). (D) Interaction between ACBD3 and the 3A protein of PV1 and
CVB3 was confirmed using a mammalian two-hybrid system. (E) A fixed number of HeLa cells and KO
cells were plated into six-well plates and incubated. On each day, live cells were counted and normalized
to the initial number of cells.
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arrayed plasmid library expressing sgRNA, we extended the library
to cover 1514 genes and successfully identified host factors re-
quired for CVB3 infection. Compared to pooled screens, arrayed
screens can be more expensive and may require automa-
tion. However, with arrayed screens, higher hit rates and lower
false-positive/-negative ratios are expected. Furthermore, arrayed
screens can have broader screen phenotypes because each well
has high individual perturbations compared to very low mixed
perturbation in the pooled screen (<0.01%). For pooled screens,
especially for highly cytopathic viruses like CVB3, a high dose of
virus could inhibit survival of virus-resistant cells, which exist in
a very small proportion. We could not obtain any hits using a
high MOI for the pooled screen with the GeCKOv2 library.
Furthermore, as we had to enrich the surviving cells for an addi-
tional 14 d post-infection, genes essential for cell proliferation
could be missed because of this longer time course. However, in
the arrayed screens, we could use a higher MOI, such as 5, and a
short time course, such as 8 h, because of the very high proportion
of virus-resistant cells (∼80%) in each well. This arrayed screen
can be preferred for assays requiring a high dose and short time
course, like early entry of viral particles. Notably, numerous ar-
rayed siRNA screens have been performed in many laboratories
and automation facilities for siRNA screening have been developed
in many research centers. Our arrayed screens are compatible with
these screening platforms. Currently, most CRIPSR screens are
conducted in a pooled format, using the lentiviral system to iden-
tify viral host factors (Ma et al. 2015; Marceau et al. 2016; Savidis
et al. 2016; Zhang et al. 2016; Kim et al. 2017; Park et al. 2017).
Although these screens have been used successfully, only a few
significant factors were selected, even though a genome-wide
sgRNA library covering over 10,000 genes was used. In fact, in a
previous pooled CRISPR screen that we performed, we were able
to identify only a single host factor for enterovirus 68 in the initial
screening (Kim et al. 2017). A strong effector in the pooled popu-
lation couldmask other genes that havemilder effects. In contrast,
we showed that genes with subtle effects or growth disadvantages,
whichmake themdifficult to be revealed in a pooled screen, can be
identified using the present method when compared with the re-
sult of pooled screen as shown in Supplemental Figures S1 and
S3. Viral infection is a complex process that involves diverse steps
such as receptor binding, endocytosis, translation, replication,
morphogenesis, and egress, and each step exploits a variety of
host factors required for the process. In our screens, we could iden-
tify various host factors for CVB3, including the entry-related fac-
tor, the translational initiation factor of viral RNA, and several
replication factors with different functions because many physi-
cally distinct cells are generated in each well by the knockout of
each gene. Furthermore, host factor genes such as DNM2, FASN,
and OSBP, which are also important for cell proliferation, could
be identified owing to the short assay time in contrast to pooled
screens.
There are new CRISPR screens that combine a pooled CRISPR
screen and single cell RNA-seq (Dixit et al. 2016; Jaitin et al. 2016;
Datlinger et al. 2017). Their major objective is to identify compre-
hensive effects induced by a single guide RNA, rather than uncov-
ering a specific target gene among a few thousand candidate genes.
Those two methods are very valuable when researchers want to
discover the effects of gene knockouts at the transcriptome level.
However, the methods would be rather inefficient when the goal
is to uncover a target gene among thousands of genes. The meth-
ods would be more suitable if the aim was to analyze the effect of
viral host genes (e.g., ACBD3 or CSDE1) after viral infection at a
single-cell level.
So far, arrayed screening formats havemostly relied on siRNA
libraries. Arrayed siRNA screens and sgRNA screenswere performed
with some minor differences. siRNAs were spotted in a multiwell
plate and reverse transfected into cells using liposomes. At 48 or
72 h post-transfection, cells were infected by virus and the viral in-
fectionwasmeasured using variousmethods. For sgRNA screens, at
5 d after transfection, cells were infected by virus and the viral
infection was measured using 3C-antibody staining and image ac-
quisition with the Operetta system. Although those siRNA screens
have advantages over pooled screens, disadvantages of siRNAs
sometimes discourage their use in large-scale screens. The biggest
issue may be “low reproducibility” across screens, which is pro-
moted by their off-target effects. Target mRNAs can be repressed
only by partial matching with the siRNA seed sequence, in con-
trast to the CRISPR system which requires a near perfect match,
not only in the seed sequence.We analyzed off-target effects using
sgRNAs specific to ACBD3 and CSDE1 with next-generation se-
quencing: No off-targetmutations were detected at sites that differ
by up to 3 nt (Supplemental Fig. S11). Here, our arrayed CRISPR
screen identified 10 candidate genes, of which eight genes were
confirmed by a secondary screen (Fig. 2C). This high rate (80%)
of confirmation by secondary screens and only two false-positives
among 1514 genes suggests that this screen was reproducible and
reliable and could be useful for large-scale screens. As shown in
Figure 5, incomplete suppression of target genes can result in
false-negatives during screening. ACBD3, which is essential even
in a trace amount of expression, could not be revealed by the
traditional siRNA screening, thus demonstrating the value of this
screen.
The arrayed CRISPR screen requires different considerations
from those of pooled screens. We chose a plasmid-based library,
expressing sgRNAs in multiwell plates. Compared with other
libraries based on individual lentiviruses or synthetic crRNA
(Metzakopian et al. 2017), including commercial sources, our plas-
mid-based library is scalable. This library was cotransfected with a
plasmid expressing Cas9 using lipid-based reagents. As shown in
Figure 1C, most genes were knocked out efficiently in HeLa cells
within 5 d, demonstrating the strength of the plasmid-based sys-
tem. However, some cells are difficult to transfect using liposomes.
These problems could be solved by electroporation, especially
A B
C
Figure 5. HeLa cells were transiently transfected with siRNAs and
sgRNAs targeting ACBD3 or CSDE1. (A) Cells were infected with CVB3,
fixed, and stained. The percentage of CVB3-infected cells (normalized
to sgRNA or siRNA control). Mean ± SEM for triplicate experiments.
(∗∗) P < 0.001, (n.s.) nonsignificant. (B,C) Cells were transfected with con-
trol siRNA, ACBD3 siRNA, and CSDE1 siRNA. The expression level of each
protein was measured by western blot using the anti-ACBD3 antibody
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using an electroporator equipped with multiwell modules, as
reported by Hultquist et al. (2016). We validated the genes using
original and newly designed sgRNAs. Moreover, we validated
some candidate genes using known chemical inhibitors (Fig.
2D), analysis of protein expression levels by western blotting
(Fig. 3), and rescue of the phenotype by cDNA expression (Figs.
3, 4). Finally, we found clues to how ACBD3 and CSDE1 affect
CVB3 infection. Additionally, live-imaging based on GFP-express-
ing virus could be optimized in future studies.
We identified two host factors, CSDE1 and ACBD3, which
are crucial for viral infection. Unlike DNM2, FASN, and OSBP,
which are also crucial for cell proliferation, these knocked-out cells
could proliferate well to produce resistant colonies (Fig. 2) and
completely block viral infection (Figs. 3, 4). We found that three
viruses belonging to the human enteroviruses require CSDE1 for
RNA translation. Other reports have described that human rhino-
virus also uses CSDE1 for IRES-dependent translation (Hunt et al.
1999; Boussadia et al. 2003). Staring et al. (2017) reported that
CSDE1 was selected as one of the host factors for poliovirus using
haploid genetic screen. These results suggest that CSDE1 is a uni-
versal factor for translation initiation in human enteroviruses.
Stone et al. (2008) reported that morpholino oligomers targeting
IRES inhibited multiple species of picornaviruses. Using a similar
approach targeting the IRES region, which interacts with CSDE1,
potential broad therapeutic inhibitors against diverse human en-
teroviruses could be developed. Concerning ACBD3, several re-
ports suggested that human enteroviruses use this factor for
replication. In this study, we added that ACBD3 minimally affects
cellular proliferation even after complete knockout. Seven acyl-
CoA-binding protein domain-containing proteins (ACBD) includ-
ing ACBD3 have been identified (Fan et al. 2010). Only ACBD3
possesses the GOLD domain at its C terminus, and this domain
mediates interaction with the Aichi virus 3A protein (McPhail
et al. 2017). The 3A proteins of diverse enteroviruses interact
with ACBD3, and inhibitors that block this interaction could be
potential broad antiviral therapeutics. In summary, we demon-
strate that these two proteins could be interesting targets to
develop anti-enteroviral therapeutics.
The two remaining host factors identified in this screen,
ADCY8 and RACK1, could also be interesting targets for further
study. Coyne et al. (2011) reported that several ADCY family pro-
teins, ADCY1, ADCY4, ADCY6, and ADCY7, were required for
CVB3 replication. In our screen, we identified ADCY8 as a host fac-
tor for CVB3. This may be due to the fact that different cells
were used for the screens or due to the difference in the efficacy
of siRNA or sgRNA targeting the ADCY family. This suggests that
the two screening methods could be complementary to each oth-
er. It has been reported that RACK1 controls IRES-mediated trans-
lation of viruses, deactivates IRF3, and limits type I interferon
signaling (Long et al. 2014; Majzoub et al. 2014). It is possible
that these two functions could be required for CVB3 infection.
Determining the molecular details of RACK1 in CVB3 infection
could also be intriguing for further study.
Methods
sgRNA oligonucleotide preparation
Oligonucleotides were purchased from Bioneer. Two complemen-
tary 24-nt oligonucleotides weremixed at 100 µM in each well in a
96-well plate. Each oligonucleotide pair was diluted to 50 µM in
TES buffer (10 mM Tris-HCl [pH7.5], 1 mM EDTA, and 100 mM
NaCl), and annealed to form a duplex in a water bath by heating
to 80°C and cooling to room temperature.
sgRNA array construction
An empty sgRNA expression vector cleaved using BsaI (New
England BioLabs) was ligated with annealed oligonucleotide mix-
tures (three oligonucleotide pairs for each gene). Ligation products
were transformed into DH5α competent cells. Transformed E. coli
cells were plated on a 10-cm LB plate with ampicillin and plasmids
are purified from them.
Pooled library screen and analysis of target genes
Human GeCKOv2 CRISPR knockout pooled library was a gift
from Feng Zhang (Addgene #1000000048) (Sanjana et al. 2014).
The oligo pool for the focused library was purchased from
CustomArray, Inc. The single-stranded oligos were amplified
to double-stranded DNA by PCR and assembled to a lentiviral
sgRNA plasmid using NEBuilder HiFi DNA Assembly Master Mix
(New England BioLabs); 3 × 107 cells were transduced with a
lentiviral sgRNA library at an MOI of 0.3. After 24 h, cells were
selected with puromycin. Those cells were cultured for ∼2 wk,
and 3 × 107 cells were infected with CVB3 (MOI 0.00001).
Genomic DNA was extracted from the initial cell population
and surviving cells from CVB3 infected populations. The region
containing the gRNA was amplified with primers F-TCTTGTGG
AAAGGACGAAACACCG and R-TCTACTATTCTTTCCCCTGCA
CTGT, using 10 µg of genomic DNA, and sequenced using an
Illumina HiSeq 4000 for 100× coverage. After sequencing, reads
were aligned to the sgRNA library and counted. Those sgRNA
counts are analyzed by MAGeCK version 0.5.5 according to the
instructions (Li et al. 2014).
Cell culture and transfection conditions
HeLa (ATCC,CCL-2) cells weremaintained inDulbecco’sModified
Eagle’s Medium (DMEM) supplemented with 10% fetal bovine se-
rum (FBS). Using 96-well plates (PerkinElmer, #6005550), 25 ng of
arrayed sgRNAs and 25 ng of Cas9 expression plasmids were re-
versely transfected to 5 × 103 HeLa cells using Lipofectamine
2000 in each well. At 5 d post-transfection, cells were used for
CVB3 infection. Single-cell-derived knockout cell lines were ob-
tained by limiting dilution.
Virus and plasmids
Coxsackievirus B3 (Nancy; ATCC, VR-30) was expanded by
growth in HeLa cells and titered using HeLa cells. The pLuCVB3
plasmid, which contains a coxsackievirus B3 subgenomic replicon
carrying the firefly luciferase gene, was provided by Eun-Seok
Jeon (Samsung Medical Center, Seoul, Korea) (Lim et al. 2012). A
CSDE1-expressing plasmid was purchased form Vigene Bioscience
(CH842097) and aplasmid encoding eGFP-CSDE1was constructed
using the eGFP-N1 plasmid (Clontech Laboratories). pCI-FLAG–
ACBD3,which contains a FLAG-taggedACBD3 gene, was obtained
from JunSasaki (FujitaHealthUniversity, Aichi, Japan) (Sasaki et al.
2012). The CheckMate mammalian two-hybrid system was
purchased from Promega Corporation. Dual luciferase reporter
plasmids containing viral IRES were a gift from Sung Key Jang
(POSTECH, Pohang, Korea).
Antibodies and chemicals
Anti-CSDE1 rabbit antibody was obtained from Bethyl Laborato-
ries (catalog no. A303-159A). ACBD3-specific rabbit antibody
(catalog no. HPA015594), murine anti-FLAG antibody (catalog
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no. F3165), and beta actin murine monoclonal antibody (catalog
no. A1978) were purchased from Sigma-Aldrich. Murinemonoclo-
nal anti-VP1 antibody was obtained from Leica (NCL-ENTERO).
Anti-RACK1 mouse antibody was purchased from BD Biosciences
(catalog no. 610177). Rabbit polyclonal anti-3C antibodywas gen-
erated by immunization with recombinant 3C protein. Secondary
antibodies conjugated to horseradish peroxidase were purchased
from Thermo Fisher Scientific (catalog no. 31466, 31430). Alexa
Fluor 488-conjugated goat anti-rabbit antibody was obtained
from Life Technologies (catalog no. A11008). Chemical inhibitor
Dynasore was purchased from Merck Millipore, and C75 and itra-
conazole were purchased from Sigma-Aldrich.
Virus infection and screening
Cells transfected with the Cas9 plasmid and sgRNA library in a
96-well plate were infected with coxsackievirus B3 at an MOI of
5 at 37°C for 8 h. Infected cells were fixed and permeabilized
with a 3:1 mixture of ice-cold methanol-acetone. Cells were
incubated with anti-3C antibody and anti-rabbit secondary anti-
body conjugated to Alexa Fluor 488 to detect infected cells, and
then counterstained with 4′,6-diamidino-2-phenylindole (DAPI)
(Thermo Fisher Scientific, #62248). Images were captured with
the Operetta system (PerkinElmer). The number of infected cells
and the total number of nuclei were quantified using Harmony
software installed on the Operetta system. The Z score for CVB3
infection was calculated as previously described (Yasunaga et al.
2014). Candidates genes were selected which are Z <−1.8 in dupli-
cate screens.
Reinfection test and replicon assay
Cells were plated to 96-well plates at 2 × 104 cells per well to test
whether knockout cells were resistant to viral infection andwheth-
er replication of the CVB subgenomic replicon was inhibited
in those cells. For the reinfection assay, 10-fold diluted CVB
(MOI 0.1∼ 0.0001) was added to each well and the cultures were
incubated at 37°C for 2 d. To measure cell viability after virus
infection, a modified 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide (MTT; Sigma-Aldrich) assay was performed as
previously described (Kim et al. 2002). The viability of infected
cells was normalized to the viability of mock-infected cells (ex-
pressed as 100%). For the replicon assay, the pLuCVB3 plasmid
was linearized with ClaI (New England BioLabs) and used as a tem-
plate for in vitro RNA transcription performed with a MEGAscript
T7 kit (Ambion) as suggested by the manufacturer’s protocol.
The in vitro transcribed replicon RNA was purified using the
TRIzol LS reagent (Invitrogen). Transfection was performed with
50 ng of replicon RNA per well with the Lipofectamine 2000
(Thermo Fisher Scientific) reagent. At 4 h post-transfection, cells
were washed, resuspended in complete growth medium, and
incubated at 37°Cor lysed in 20 µL of lysis buffer (0 h). At indicated
time points, cells were washed and lysed in lysis buffer. Luciferase
activity was measured using a luciferase assay kit (Promega Cor-
poration) according to the manufacturer’s protocol and a lumin-
ometer (LB960 centro XS3, Berthold Technologies). Luciferase
activity was expressed in fold increase as compared with the activ-
ity measured at 0 h.
RNA interference
CSDE1 siRNA (L-015834-00) and RACK1 siRNA (L-006876-00)
were obtained from Dharmacon. Control and human ACBD3
siRNAs have been described previously (Dorobantu et al. 2014).
siRNAs were used at a concentration of 20 nM. Cells were trans-
fected with siRNAs in six-well plates using Lipofectamine 2000
(Thermo Fisher Scientific). After 24 h, cells were trypsinized and
replated in 96-well or 12-well plates, and virus infectionor replicon
RNA transfection was performed 2 d later. Depletion of the target
proteins was confirmed by immunoblot analysis. The blots were
developed using a LAS 4000 imager (Fujifilm).
IRES activity test
IRES activity was measured as previously described with minor
modification (Kang et al. 2015). Wild-type (HeLa) and CSDE1
knockout cells were plated into 96-well plate and transfected
with reporter plasmids using Lipofectamine 2000. Forty-eight
hours post-transfection, firefly and Renilla luciferase activities
were measured.
Isolation of CVB3-resistant colonies
HeLa cells transduced with the GeCKO library or transfected with
Cas9 plasmid and candidate sgRNAs were infected with CVB3.
Infected cells were washed and changed to complete medium.
The culture mediumwas changed every 2 or 3 d. After 14 d, surviv-
ing colonies were fixed and stained by crystal violet (0.05%) in
phosphate buffered saline (PBS) solution containing 1% formalde-
hyde and 25% methanol or isolated and expanded for further
analysis.
Data access
The deep sequencing data from this study have been submitted to
theNCBI Sequence ReadArchive (SRA; https://www.ncbi.nlm.nih.
gov/sra) under accession number SRP117996. The plasmids used
here have been deposited at Addgene (#110724).
Acknowledgments
This research was supported by grants from IBS (IBS-R021-D1) to
J.-S.K., from the Basic Science Research Program through the
National Research Foundation of Korea (NRF) funded by the
Ministry of Science, ICT & Future Planning (2016R1C1B2009585),
and from the National Research Council of Science & Technology
(NST) grant from the Korea government (MSIP) (no. CRC-16-01-
KRICT) to C.K.
Author contributions: H.S.K., K.L., S.-J.K., S.C., H.J.S., and C.K.
performed the experiments. H.S.K. performed bioinformatics
analyses. J.-S.K. and C.K. supervised the research.
References
Anderson EC, Hunt SL, Jackson RJ. 2007. Internal initiation of translation
from the human rhinovirus-2 internal ribosome entry site requires
the binding of Unr to two distinct sites on the 5′ untranslated region.
J Gen Virol 88: 3043–3052.
Bae S, Kweon J, Kim HS, Kim JS. 2014a. Microhomology-based choice of
Cas9 nuclease target sites. Nat Methods 11: 705–706.
Bae S, Park J, Kim JS. 2014b. Cas-OFFinder: a fast and versatile algorithm that
searches for potential off-target sites of Cas9 RNA-guided endonucleas-
es. Bioinformatics 30: 1473–1475.
Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A,
Hong JS, Horwitz MS, Crowell RL, Finberg RW. 1997. Isolation of a com-
mon receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science
275: 1320–1323.
Blomen VA, Majek P, Jae LT, Bigenzahn JW, Nieuwenhuis J, Staring J, Sacco
R, van Diemen FR, Olk N, Stukalov A, et al. 2015. Gene essentiality and
synthetic lethality in haploid human cells. Science 350: 1092–1096.
Boussadia O, Niepmann M, Creancier L, Prats AC, Dautry F, Jacquemin-
Sablon H. 2003. Unr is required in vivo for efficient initiation of trans-
lation from the internal ribosome entry sites of both rhinovirus and




 Cold Spring Harbor Laboratory Press on April 21, 2020 - Published by genome.cshlp.orgDownloaded from 
Buehler E, Chen YC, Martin S. 2012. C911: a bench-level control for
sequence specific siRNA off-target effects. PLoS One 7: e51942.
Cho SW, Kim S, KimY, Kweon J, KimHS, Bae S, Kim JS. 2014. Analysis of off-
target effects of CRISPR/Cas-derived RNA-guided endonucleases and
nickases. Genome Res 24: 132–141.
Coyne CB, Bergelson JM. 2006. Virus-induced Abl and Fyn kinase signals
permit coxsackievirus entry through epithelial tight junctions. Cell
124: 119–131.
Coyne CB, Bozym R, Morosky SA, Hanna SL, Mukherjee A, Tudor M, Kim
KS, Cherry S. 2011. Comparative RNAi screening reveals host factors in-
volved in enterovirus infection of polarized endothelial monolayers.
Cell Host Microbe 9: 70–82.
Datlinger P, Rendeiro AF, Schmidl C, Krausgruber T, Traxler P, Klughammer
J, Schuster LC, Kuchler A, Alpar D, Bock C. 2017. Pooled CRISPR screen-
ing with single-cell transcriptome readout. Nat Methods 14: 297–301.
Dixit A, Parnas O, Li B, Chen J, Fulco CP, Jerby-Arnon L, Marjanovic ND,
Dionne D, Burks T, Raychowdhury R, et al. 2016. Perturb-Seq: dissecting
molecular circuits with scalable single-cell RNA profiling of pooled ge-
netic screens. Cell 167: 1853–1866.e17.
Dorobantu CM, van der Schaar HM, Ford LA, Strating JR, Ulferts R, Fang Y,
Belov G, van Kuppeveld FJ. 2014. Recruitment of PI4KIIIβ to coxsackie-
virus B3 replication organelles is independent of ACBD3, GBF1, and
Arf1. J Virol 88: 2725–2736.
Fan J, Liu J, Culty M, Papadopoulos V. 2010. Acyl-coenzyme A binding
domain containing 3 (ACBD3; PAP7; GCP60): an emerging signaling
molecule. Prog Lipid Res 49: 218–234.
Fields BN, Knipe DM, Howley PM. 2007. Fields’ virology. Wolters Kluwer
Health/Lippincott Williams & Wilkins, Philadelphia, PA.
Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK. 2014. Improving CRISPR-
Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol
32: 279–284.
Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen Y, Whitehead EH,
Guimaraes C, Panning B, Ploegh HL, Bassik MC, et al. 2014. Genome-
scale CRISPR-mediated control of gene repression and activation. Cell
159: 647–661.
Hsu NY, Ilnytska O, Belov G, Santiana M, Chen YH, Takvorian PM, Pau C,
van der Schaar H, Kaushik-Basu N, Balla T, et al. 2010. Viral reorganiza-
tion of the secretory pathway generates distinct organelles for RNA rep-
lication. Cell 141: 799–811.
Hultquist JF, Schumann K,Woo JM,Manganaro L, McGregorMJ, Doudna J,
Simon V, Krogan NJ, Marson A. 2016. A Cas9 ribonucleoprotein plat-
form for functional genetic studies of HIV-host interactions in primary
human T cells. Cell Rep 17: 1438–1452.
Hunt SL, Hsuan JJ, Totty N, Jackson RJ. 1999. unr, a cellular cytoplasmic
RNA-binding proteinwith five cold-shock domains, is required for inter-
nal initiation of translation of human rhinovirus RNA. Genes Dev 13:
437–448.
Jaitin DA, Weiner A, Yofe I, Lara-Astiaso D, Keren-Shaul H, David E, Salame
TM, Tanay A, van Oudenaarden A, Amit I. 2016. Dissecting immune cir-
cuits by linking CRISPR-pooled screens with single-cell RNA-seq. Cell
167: 1883–1896.e15.
Kaelin WG Jr. 2012. Molecular biology. Use and abuse of RNAi to study
mammalian gene function. Science 337: 421–422.
Kang H, Kim C, Kim DE, Song JH, Choi M, Choi K, Kang M, Lee K, Kim HS,
Shin JS, et al. 2015. Synergistic antiviral activity of gemcitabine and ri-
bavirin against enteroviruses. Antiviral Res 124: 1–10.
Kim JH, Park JB, Bae PK, Kim HS, Kim DW, Ahn JK, Lee CK. 2002.
Establishment and use of a cell line expressing HSV-1 thymidine kinase
to characterize viral thymidine kinase-dependent drug-resistance.
Antiviral Res 54: 163–174.
Kim D, Bae S, Park J, Kim E, Kim S, Yu HR, Hwang J, Kim JI, Kim JS. 2015.
Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects
in human cells. Nat Methods 12: 237–243.
Kim HS, Lee K, Bae S, Park J, Lee CK, Kim M, Kim E, Kim M, Kim S, Kim C,
et al. 2017. CRISPR/Cas9-mediated gene knockout screens and target
identification via whole-genome sequencing uncover host genes re-
quired for picornavirus infection. J Biol Chem 292: 10664–10671.
Koike-Yusa H, Li Y, Tan EP, Velasco-Herrera MDC, Yusa K. 2014. Genome-
wide recessive genetic screening in mammalian cells with a lentiviral
CRISPR-guide RNA library. Nat Biotechnol 32: 267–273.
Lanke KH, van der Schaar HM, Belov GA, Feng Q, Duijsings D, Jackson CL,
Ehrenfeld E, van Kuppeveld FJ. 2009. GBF1, a guanine nucleotide ex-
change factor for Arf, is crucial for coxsackievirus B3 RNA replication.
J Virol 83: 11940–11949.
Lei X, Xiao X, Zhang Z, Ma Y, Qi J, Wu C, Xiao Y, Zhou Z, He B, Wang J.
2017. The Golgi protein ACBD3 facilitates Enterovirus 71 replication
by interacting with 3A. Sci Rep 7: 44592.
Li W, Xu H, Xiao T, Cong L, LoveMI, Zhang F, Irizarry RA, Liu JS, BrownM,
Liu XS. 2014. MAGeCK enables robust identification of essential
genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol
15: 554.
Lim BK, Yun SH, Gil CO, Ju ES, Choi JO, Kim DK, Jeon ES. 2012.
Foreign gene transfer to cardiomyocyte using a replication-defective
recombinant coxsackievirus B3 without cytotoxicity. Intervirology 55:
201–209.
Long L, Deng Y, Yao F, Guan D, Feng Y, Jiang H, Li X, Hu P, Lu X, Wang H,
et al. 2014. Recruitment of phosphatase PP2A by RACK1 adaptor protein
deactivates transcription factor IRF3 and limits type I interferon signal-
ing. Immunity 40: 515–529.
Ma H, Dang Y,Wu Y, Jia G, Anaya E, Zhang J, Abraham S, Choi JG, Shi G, Qi
L, et al. 2015. A CRISPR-based screen identifies genes essential for
West-Nile-virus-induced cell death. Cell Rep 12: 673–683.
Majzoub K, HafirassouML,Meignin C, Goto A,Marzi S, Fedorova A, Verdier
Y, Vinh J, Hoffmann JA, Martin F, et al. 2014. RACK1 controls IRES-me-
diated translation of viruses. Cell 159: 1086–1095.
Marceau CD, Puschnik AS, Majzoub K, Ooi YS, Brewer SM, Fuchs G,
SwaminathanK,MataMA, Elias JE, SarnowP, et al. 2016. Genetic dissec-
tion of Flaviviridae host factors through genome-scale CRISPR screens.
Nature 535: 159–163.
McCleland ML, Mesh K, Lorenzana E, Chopra VS, Segal E, Watanabe C,
Haley B, Mayba O, Yaylaoglu M, Gnad F, et al. 2016. CCAT1 is an en-
hancer-templated RNA that predicts BET sensitivity in colorectal cancer.
J Clin Invest 126: 639–652.
McPhail JA, Ottosen EH, Jenkins ML, Burke JE. 2017. The molecular basis of
Aichi virus 3A protein activation of phosphatidylinositol 4 kinase IIIβa,
PI4KB, through ACBD3. Structure 25: 121–131.
Mesmin B, Bigay J, Moser von Filseck J, Lacas-Gervais S, Drin G, Antonny B.
2013. A four-step cycle driven by PI(4)P hydrolysis directs sterol/PI(4)P
exchange by the ER-Golgi tether OSBP. Cell 155: 830–843.
Metzakopian E, Strong A, Iyer V, Hodgkins A, Tzelepis K, Antunes L,
Friedrich MJ, Kang Q, Davidson T, Lamberth J, et al. 2017. Enhancing
the genome editing toolbox: genome wide CRISPR arrayed libraries.
Sci Rep 7: 2244.
Paek KY, Kim CS, Park SM, Kim JH, Jang SK. 2008. RNA-binding protein
hnRNPDmodulates internal ribosome entry site-dependent translation
of hepatitis C virus RNA. J Virol 82: 12082–12093.
Park RJ, Wang T, Koundakjian D, Hultquist JF, Lamothe-Molina P, Monel B,
Schumann K, Yu H, Krupzcak KM, Garcia-Beltran W, et al. 2017.
A genome-wide CRISPR screen identifies a restricted set of HIV host
dependency factors. Nat Genet 49: 193–203.
Patel KP, Coyne CB, Bergelson JM. 2009. Dynamin- and lipid raft-
dependent entry of decay-accelerating factor (DAF)-binding and
non-DAF-binding coxsackieviruses into nonpolarized cells. J Virol 83:
11064–11077.
Roulin PS, Lotzerich M, Torta F, Tanner LB, van Kuppeveld FJ, Wenk
MR, Greber UF. 2014. Rhinovirus uses a phosphatidylinositol 4-
phosphate/cholesterol counter-current for the formation of repli-
cation compartments at the ER-Golgi interface. Cell Host Microbe 16:
677–690.
Sanjana NE, Shalem O, Zhang F. 2014. Improved vectors and genome-wide
libraries for CRISPR screening. Nat Methods 11: 783–784.
Sasaki J, Ishikawa K, Arita M, Taniguchi K. 2012. ACBD3-mediated recruit-
ment of PI4KB to picornavirus RNA replication sites. EMBO J 31:
754–766.
Savidis G, McDougall WM, Meraner P, Perreira JM, Portmann JM, Trincucci
G, John SP, Aker AM, Renzette N, Robbins DR, et al. 2016. Identification
of Zika virus and dengue virus dependency factors using functional
genomics. Cell Rep 16: 232–246.
ShalemO, Sanjana NE, Hartenian E, Shi X, Scott DA,Mikkelsen TS, Heckl D,
Ebert BL, Root DE, Doench JG, et al. 2014. Genome-scale CRISPR-Cas9
knockout screening in human cells. Science 343: 84–87.
Staring J, von Castelmur E, Blomen VA, van den Hengel LG, BrockmannM,
Baggen J, Thibaut HJ, Nieuwenhuis J, Janssen H, van Kuppeveld FJ, et al.
2017. PLA2G16 represents a switch between entry and clearance of
Picornaviridae. Nature 541: 412–416.
Stone JK, RijnbrandR, SteinDA,MaY, YangY, Iversen PL, Andino R. 2008. A
morpholino oligomer targeting highly conserved internal ribosome en-
try site sequence is able to inhibit multiple species of picornavirus.
Antimicrob Agents Chemother 52: 1970–1981.
Strating JR, van der Linden L, Albulescu L, Bigay J, Arita M, Delang L,
Leyssen P, van der Schaar HM, Lanke KH, Thibaut HJ, et al. 2015.
Itraconazole inhibits enterovirus replication by targeting the oxy-
sterol-binding protein. Cell Rep 10: 600–615.
Strezoska Z, Perkett MR, Chou ET, Maksimova E, Anderson EM, McClelland
S, Kelley ML, Vermeulen A, Smith AVB. 2017. High-content analysis
screening for cell cycle regulators using arrayed synthetic crRNA librar-
ies. J Biotechnol 251: 189–200.
Tan J, Martin SE. 2016. Validation of synthetic CRISPR reagents as a tool for
arrayed functional genomic screening. PLoS One 11: e0168968.
Teoule F, Brisac C, Pelletier I, Vidalain PO, Jegouic S, Mirabelli C, BessaudM,
Combelas N, Autret A, Tangy F, et al. 2013. TheGolgi protein ACBD3, an
Arrayed CRISPR screen with image-based assay
Genome Research 867
www.genome.org
 Cold Spring Harbor Laboratory Press on April 21, 2020 - Published by genome.cshlp.orgDownloaded from 
interactor for poliovirus protein 3A, modulates poliovirus replication.
J Virol 87: 11031–11046.
Wang T, Wei JJ, Sabatini DM, Lander ES. 2014. Genetic screens in human
cells using the CRISPR-Cas9 system. Science 343: 80–84.
Wilsky S, Sobotta K, Wiesener N, Pilas J, Althof N, Munder T, Wutzler P,
Henke A. 2012. Inhibition of fatty acid synthase by amentoflavone
reduces coxsackievirus B3 replication. Arch Virol 157: 259–269.
Yasunaga A, Hanna SL, Li J, Cho H, Rose PP, Spiridigliozzi A, Gold B,
Diamond MS, Cherry S. 2014. Genome-wide RNAi screen identifies
broadly-acting host factors that inhibit arbovirus infection. PLoS
Pathog 10: e1003914.
Zhang R, Miner JJ, Gorman MJ, Rausch K, Ramage H, White JP, Zuiani A,
Zhang P, Fernandez E, Zhang Q, et al. 2016. A CRISPR screen defines
a signal peptide processing pathway required by flaviviruses. Nature
535: 164–168.




 Cold Spring Harbor Laboratory Press on April 21, 2020 - Published by genome.cshlp.orgDownloaded from 
 10.1101/gr.230250.117Access the most recent version at doi:
2018 28: 859-868 originally published online April 30, 2018Genome Res. 
  
Heon Seok Kim, Kyungjin Lee, Seong-Jun Kim, et al. 
  
host genes required for coxsackievirus infection




















Commons License (Attribution-NonCommercial 4.0 International), as described at 




 click here.top right corner of the article or 
Receive free email alerts when new articles cite this article - sign up in the box at the
 http://genome.cshlp.org/subscriptions
go to: Genome Research To subscribe to 
© 2018 Kim et al.; Published by Cold Spring Harbor Laboratory Press
 Cold Spring Harbor Laboratory Press on April 21, 2020 - Published by genome.cshlp.orgDownloaded from 
